Wall Street brokerages expect that Intuitive Surgical, Inc. (NASDAQ:ISRG) will report $845.66 million in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Intuitive Surgical’s earnings. The highest sales estimate is $852.43 million and the lowest is $830.00 million. Intuitive Surgical posted sales of $756.90 million during the same quarter last year, which suggests a positive year over year growth rate of 11.7%. The company is expected to report its next earnings results on Tuesday, January 23rd.

According to Zacks, analysts expect that Intuitive Surgical will report full-year sales of $845.66 million for the current fiscal year, with estimates ranging from $3.07 billion to $3.10 billion. For the next year, analysts anticipate that the company will report sales of $3.43 billion per share, with estimates ranging from $3.25 billion to $3.53 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Intuitive Surgical.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, topping the consensus estimate of $1.99 by $0.78. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The business had revenue of $806.10 million during the quarter, compared to analyst estimates of $753.25 million. During the same period last year, the business posted $2.06 earnings per share. The company’s quarterly revenue was up 18.0% on a year-over-year basis.

Several research firms have recently commented on ISRG. Vetr upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $113.37 price target for the company in a research report on Thursday, August 17th. Wedbush reiterated a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 10th. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $436.00 target price for the company in a report on Tuesday, November 14th. Royal Bank of Canada reiterated a “hold” rating and issued a $333.33 target price on shares of Intuitive Surgical in a report on Friday, September 1st. Finally, Canaccord Genuity reiterated a “hold” rating on shares of Intuitive Surgical in a report on Tuesday, October 17th. Five analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $155.78.

In other news, Director Alan J. Levy sold 2,997 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.35, for a total transaction of $1,112,935.95. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Mark J. Rubash sold 6,000 shares of Intuitive Surgical stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $395.95, for a total value of $2,375,700.00. Following the sale, the director now owns 5,453 shares in the company, valued at approximately $2,159,115.35. The disclosure for this sale can be found here. Insiders have sold a total of 55,944 shares of company stock valued at $21,432,971 over the last ninety days. 2.20% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Wilbanks Smith & Thomas Asset Management LLC increased its position in Intuitive Surgical by 0.5% in the 2nd quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 370 shares of the medical equipment provider’s stock valued at $346,000 after acquiring an additional 2 shares during the period. Chilton Investment Co. LLC boosted its holdings in Intuitive Surgical by 0.4% in the 2nd quarter. Chilton Investment Co. LLC now owns 502 shares of the medical equipment provider’s stock valued at $470,000 after purchasing an additional 2 shares in the last quarter. Alps Advisors Inc. boosted its holdings in Intuitive Surgical by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 647 shares of the medical equipment provider’s stock valued at $605,000 after purchasing an additional 2 shares in the last quarter. Bronfman E.L. Rothschild L.P. boosted its holdings in Intuitive Surgical by 1.4% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 284 shares of the medical equipment provider’s stock valued at $266,000 after purchasing an additional 4 shares in the last quarter. Finally, Wetherby Asset Management Inc. boosted its holdings in Intuitive Surgical by 1.4% in the 2nd quarter. Wetherby Asset Management Inc. now owns 361 shares of the medical equipment provider’s stock valued at $338,000 after purchasing an additional 5 shares in the last quarter. Institutional investors and hedge funds own 32.80% of the company’s stock.

Intuitive Surgical (ISRG) opened at $373.55 on Tuesday. Intuitive Surgical has a 52-week low of $207.94 and a 52-week high of $405.05. The company has a market capitalization of $42,534.46, a price-to-earnings ratio of 50.24, a PEG ratio of 5.27 and a beta of 0.48.

ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.watchlistnews.com/analysts-anticipate-intuitive-surgical-inc-isrg-will-post-quarterly-sales-of-845-66-million/1758544.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Get a free copy of the Zacks research report on Intuitive Surgical (ISRG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.